Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q4
Sell
-100
Closed -$26K 872
2021
Q3
$26K Buy
+100
New +$27.3K ﹤0.01% 605
2021
Q1
Sell
-10
Closed -$2K 805
2020
Q4
$2K Buy
+10
New +$1.99K ﹤0.01% 711
2018
Q3
Sell
-414
Closed -$43K 821
2018
Q2
$43K Hold
414
﹤0.01% 558
2018
Q1
$41K Sell
414
-126
-23% -$11.9K ﹤0.01% 544
2017
Q4
$46K Buy
+540
New +$44.6K ﹤0.01% 577
2017
Q1
Sell
-482
Closed -$30K 1174
2016
Q4
$30K Hold
482
﹤0.01% 651
2016
Q3
$31K Hold
482
﹤0.01% 650
2016
Q2
$30K Hold
482
﹤0.01% 628
2016
Q1
$28K Hold
482
﹤0.01% 651
2015
Q4
$26K Sell
482
-794
-62% -$44.8K ﹤0.01% 666
2015
Q3
$65K Hold
1,276
﹤0.01% 572
2015
Q2
$72K Hold
1,276
﹤0.01% 564
2015
Q1
$92K Sell
1,276
-488
-28% -$31.7K ﹤0.01% 568
2014
Q4
$99K Hold
1,764
﹤0.01% 570
2014
Q3
$87K Hold
1,764
﹤0.01% 594
2014
Q2
$89K Hold
1,764
﹤0.01% 583
2014
Q1
$79K Buy
+1,764
New +$79.2K ﹤0.01% 600

Other funds holding RMD

MUFG Americas's RMD Position: Q4 2021 in Review

MUFG Americas sold out of ResMed (RMD) in Q4 2021, closing a stake of 100 shares — an estimated $26K sold.

MUFG Americas first reported a position in RMD in Q1 2014 and held it in 17 quarters. The position peaked at $99K in Q4 2014. 723 funds tracked by Wall St. Rank hold RMD as of Q4 2021.

  • MUFG Americas reported no remaining ResMed position as of Q4 2021 after selling out during the quarter.
  • MUFG Americas sold 100 ResMed shares in Q4 2021, an estimated $26K.
  • MUFG Americas first reported a position in ResMed in Q1 2014 and held it in 17 quarters.
  • MUFG Americas's ResMed position peaked at $99K in Q4 2014.
  • 723 funds tracked by Wall St. Rank held ResMed as of Q4 2021.

Based on MUFG Americas's 13F filing for Q4 2021, filed 9 Feb 2022.